The most assertive raise of the three came from BTIG’s Mark Massaro, who now feels GeneDx is worth $125 per share, well up from the analyst’s preceding level of $100. Massaro remains bullish on the …
Why GeneDx Holdings Stock Crushed It Again Today
view original post